Literature DB >> 21686283

Vimentin: Central hub in EMT induction?

Johanna Ivaska1.   

Abstract

Epithelial-to-mesenchymal transition (EMT) is a critical event in the induction of cell motility and increased survival both under physiological situations like wound healing and during development as well as in malignant cells undergoing invasion and metastasis. Vimentin is an intermediate filament protein which is characteristically upregulated in cells undergoing EMT. For decades vimentin has been considered as a marker for EMT but its functional contribution to the process has remained unclear. Our data demonstrate that vimentin contributes to EMT via upregulating the gene expression of several EMT-linked genes. Especially, we find that vimentin regulates EMT associated induced migration via upregulation of the expression of receptor tyrosine kinase Axl. In addition to our data, several other exciting recent studies support the notion that vimentin in fact functions as a positive regulator of EMT and upregulation of vimentin appears to be a prerequisite for EMT induction.

Entities:  

Year:  2011        PMID: 21686283      PMCID: PMC3116616          DOI: 10.4161/sgtp.2.1.15114

Source DB:  PubMed          Journal:  Small GTPases        ISSN: 2154-1248


  17 in total

1.  Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer.

Authors:  K Vuoriluoto; H Haugen; S Kiviluoto; J-P Mpindi; J Nevo; C Gjerdrum; C Tiron; J B Lorens; J Ivaska
Journal:  Oncogene       Date:  2010-11-08       Impact factor: 9.867

2.  The intermediate filament protein vimentin binds specifically to a recombinant integrin alpha2/beta1 cytoplasmic tail complex and co-localizes with native alpha2/beta1 in endothelial cell focal adhesions.

Authors:  Stephanie Kreis; Hans-Joachim Schönfeld; Chantal Melchior; Beat Steiner; Nelly Kieffer
Journal:  Exp Cell Res       Date:  2005-04-15       Impact factor: 3.905

3.  R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer.

Authors:  Sacha J Holland; Alison Pan; Christian Franci; Yuanming Hu; Betty Chang; Weiqun Li; Matt Duan; Allan Torneros; Jiaxin Yu; Thilo J Heckrodt; Jing Zhang; Pingyu Ding; Ayodele Apatira; Joanne Chua; Ralf Brandt; Polly Pine; Dane Goff; Rajinder Singh; Donald G Payan; Yasumichi Hitoshi
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

4.  An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies.

Authors:  X Ye; Y Li; S Stawicki; S Couto; J Eastham-Anderson; D Kallop; R Weimer; Y Wu; L Pei
Journal:  Oncogene       Date:  2010-07-05       Impact factor: 9.867

5.  Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors.

Authors:  R Hoshino; Y Chatani; T Yamori; T Tsuruo; H Oka; O Yoshida; Y Shimada; S Ari-i; H Wada; J Fujimoto; M Kohno
Journal:  Oncogene       Date:  1999-01-21       Impact factor: 9.867

Review 6.  TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

7.  Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition.

Authors:  Melissa G Mendez; Shin-Ichiro Kojima; Robert D Goldman
Journal:  FASEB J       Date:  2010-01-22       Impact factor: 5.191

8.  Vimentin contributes to human mammary epithelial cell migration.

Authors:  C Gilles; M Polette; J M Zahm; J M Tournier; L Volders; J M Foidart; P Birembaut
Journal:  J Cell Sci       Date:  1999-12       Impact factor: 5.285

9.  Keeping the vimentin network under control: cell-matrix adhesion-associated plectin 1f affects cell shape and polarity of fibroblasts.

Authors:  Gerald Burgstaller; Martin Gregor; Lilli Winter; Gerhard Wiche
Journal:  Mol Biol Cell       Date:  2010-08-11       Impact factor: 4.138

10.  Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts.

Authors:  B Eckes; D Dogic; E Colucci-Guyon; N Wang; A Maniotis; D Ingber; A Merckling; F Langa; M Aumailley; A Delouvée; V Koteliansky; C Babinet; T Krieg
Journal:  J Cell Sci       Date:  1998-07       Impact factor: 5.285

View more
  64 in total

1.  FXR silencing in human colon cancer by DNA methylation and KRAS signaling.

Authors:  Ann M Bailey; Le Zhan; Dipen Maru; Imad Shureiqi; Curtis R Pickering; Galina Kiriakova; Julie Izzo; Nan He; Caimiao Wei; Veerabhadran Baladandayuthapani; Han Liang; Scott Kopetz; Garth Powis; Grace L Guo
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-31       Impact factor: 4.052

2.  Vimentin DNA methylation predicts survival in breast cancer.

Authors:  Jacob Ulirsch; Cheng Fan; George Knafl; Ming Jing Wu; Brett Coleman; Charles M Perou; Theresa Swift-Scanlan
Journal:  Breast Cancer Res Treat       Date:  2012-12-13       Impact factor: 4.872

Review 3.  Intermediate Filaments and the Regulation of Cell Motility during Regeneration and Wound Healing.

Authors:  Fang Cheng; John E Eriksson
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-09-01       Impact factor: 10.005

4.  Selective regulation of Notch ligands during angiogenesis is mediated by vimentin.

Authors:  Daniel Antfolk; Marika Sjöqvist; Fang Cheng; Kimmo Isoniemi; Camille L Duran; Adolfo Rivero-Muller; Christian Antila; Rasmus Niemi; Sebastian Landor; Carlijn V C Bouten; Kayla J Bayless; John E Eriksson; Cecilia M Sahlgren
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

5.  Effect of hydrogel stiffness on morphology and gene expression pattern of CD44high oral squamous cell carcinoma cells.

Authors:  Hideo Shigeishi; Sho Yokoyama; Hiroshi Murodumi; Miyuki Sakuma; Hiroki Kato; Koichiro Higashikawa; Masaaki Takechi; Kouji Ohta; Masaru Sugiyama
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

6.  DNA hypermethylation of the vimentin gene inversely correlates with vimentin expression in intestinal- and diffuse-type gastric cancer.

Authors:  Hui Cong; Ru-Yong Yao; Zhen-Qing Sun; Wen-Sheng Qiu; Ya-Sai Yao; Tong-Tong Feng; Chao Xin; Jun Liang; L U Yue
Journal:  Oncol Lett       Date:  2015-11-18       Impact factor: 2.967

Review 7.  Modulation of cytoskeletal dynamics by mammalian nucleoside diphosphate kinase (NDPK) proteins.

Authors:  Natasha T Snider; Peter J Altshuler; M Bishr Omary
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-09-20       Impact factor: 3.000

8.  Glucose-regulated protein 78 (GRP78) regulates colon cancer metastasis through EMT biomarkers and the NRF-2/HO-1 pathway.

Authors:  Yu-Jia Chang; Wei-Yu Chen; Chien-Yu Huang; Hui-Hsiung Liu; Po-Li Wei
Journal:  Tumour Biol       Date:  2014-11-28

9.  Down-regulation of Gli-1 inhibits hepatocellular carcinoma cell migration and invasion.

Authors:  Jing-Song Chen; Hua-Shu Li; Jiong-Qiang Huang; Long-Juan Zhang; Xi-Lin Chen; Qian Wang; Jian Lei; Ju-Tao Feng; Qin Liu; Xiao-Hui Huang
Journal:  Mol Cell Biochem       Date:  2014-05-03       Impact factor: 3.396

10.  Pituitary tumor transforming gene PTTG2 induces psoriasis by regulating vimentin and E-cadherin expression.

Authors:  Xiao-Bing Liu; Feng Li; Ya-Qin Li; Fan Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.